Mastering fate: Redistributing a pioneer protein to rewrite leukemia's script
Open Access
- 22 January 2025
- journal article
- editorial
- Published by Wiley in HemaSphere
- Vol. 9 (1) , e70084
Abstract
No abstract availableThis publication has 6 references indexed in Scilit:
- Current status and research directions in acute myeloid leukemiaBlood Cancer Journal, 2024
- Pharmacological restriction of genomic binding sites redirects PU.1 pioneer transcription factor activityNature Genetics, 2024
- Induction of AML cell differentiation using HOXA9/DNA binding inhibitors as a potential therapeutic option for HOXA9‐dependent AMLHemaSphere, 2024
- An Overview of Targeted Therapies in Acute Myeloid LeukemiaHemaSphere, 2023
- Targeting transcription factors in cancer — from undruggable to realityNature Reviews Cancer, 2019
- Genome-scale definition of the transcriptional programme associated with compromised PU.1 activity in acute myeloid leukaemiaLeukemia, 2015